Chernyavskiy et al., 2016 - Google Patents
Quality of life after surgical ablation of persistent atrial fibrillation: a prospective evaluationChernyavskiy et al., 2016
- Document ID
- 8018563008199899120
- Author
- Chernyavskiy A
- Kareva Y
- Pak I
- Rakhmonov S
- Pokushalov E
- Romanov A
- Publication year
- Publication venue
- Heart, Lung and Circulation
External Links
Snippet
Aim To compare the quality of life (QoL) of patients with persistent atrial fibrillation (AF) and ischaemic heart disease after modified mini-maze (MM) procedure or pulmonary vein isolation (PVI) using radiofrequency ablation (RFA) with patients in the control group …
- 206010003658 Atrial fibrillation 0 title abstract description 71
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/04—Detecting, measuring or recording bioelectric signals of the body of parts thereof
- A61B5/0402—Electrocardiography, i.e. ECG
- A61B5/0452—Detecting specific parameters of the electrocardiograph cycle
- A61B5/046—Detecting fibrillation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Olsson et al. | Atrial flutter and fibrillation in patients with pulmonary hypertension | |
| Dagres et al. | Risk stratification after myocardial infarction: is left ventricular ejection fraction enough to prevent sudden cardiac death? | |
| Serpytis et al. | Impact of atrial fibrillation on cognitive function, psychological distress, quality of life, and impulsiveness | |
| Cipriani et al. | The electrocardiographic “triangular QRS-ST-T waveform” pattern in patients with ST-segment elevation myocardial infarction: Incidence, pathophysiology and clinical implications | |
| Huffman et al. | Anxiety, independent of depressive symptoms, is associated with in-hospital cardiac complications after acute myocardial infarction | |
| Suman-Horduna et al. | Quality of life and functional capacity in patients with atrial fibrillation and congestive heart failure | |
| Khairy et al. | Sudden death and defibrillators in transposition of the great arteries with intra-atrial baffles: a multicenter study | |
| Mantovan et al. | Relationship of quality of life with procedural success of atrial fibrillation (AF) ablation and postablation AF burden: substudy of the STAR AF randomized trial | |
| Alexander et al. | Comparison of the extent of coronary artery disease in patients with versus without interatrial block and implications for new-onset atrial fibrillation | |
| Yoshida et al. | Troponin elevation after radiofrequency catheter ablation of atrial fibrillation: relevance to AF substrate, procedural outcomes, and reverse structural remodeling | |
| Scirica et al. | Ischemia detected on continuous electrocardiography after acute coronary syndrome: observations from the MERLIN–TIMI 36 (Metabolic Efficiency With Ranolazine for Less Ischemia in Non–ST-Elevation Acute Coronary Syndrome–Thrombolysis In Myocardial Infarction 36) trial | |
| Fiala et al. | A prospective evaluation of haemodynamics, functional status, and quality of life after radiofrequency catheter ablation of long-standing persistent atrial fibrillation | |
| Perez-Villacastin et al. | Epidemiology of atrial fibrillation in Spain in the past 20 years | |
| Reddy et al. | Atrial fibrillation ablation in patients with gastroesophageal reflux disease or irritable bowel syndrome—the heart to gut connection! | |
| White et al. | Impact of epicardial anterior fat pad retention on postcardiothoracic surgery atrial fibrillation incidence: the AFIST-III Study | |
| Wang et al. | Efficiency of radiofrequency ablation for surgical treatment of chronic atrial fibrillation in rheumatic valvular disease | |
| Patel et al. | Influence of presenting electrocardiographic findings on the treatment and outcomes of patients with non–ST-segment elevation myocardial infarction | |
| El-Assaad et al. | Use of dofetilide in adult patients with atrial arrhythmias and congenital heart disease: a PACES collaborative study | |
| Sousa et al. | Impact of free thyroxine on the outcomes of left atrial ablation procedures | |
| Ejima et al. | Long-term outcome and preprocedural predictors of atrial tachyarrhythmia recurrence following pulmonary vein antrum isolation-based catheter ablation in patients with non-paroxysmal atrial fibrillation | |
| Badenco et al. | Respective role of surface electrocardiogram and His bundle recordings to assess the risk of atrioventricular block after transcatheter aortic valve replacement | |
| Osmancik et al. | Improvement in the quality of life of patients with persistent or long-standing persistent atrial fibrillation after hybrid ablation | |
| Chernyavskiy et al. | Quality of life after surgical ablation of persistent atrial fibrillation: a prospective evaluation | |
| Ledwoch et al. | Impact of transcatheter mitral valve repair on ventricular arrhythmias | |
| Andrade et al. | Antiarrhythmic use from 1991 to 2007: insights from the Canadian Registry of Atrial Fibrillation (CARAF I and II) |